BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20150621)

  • 1. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.
    Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
    Anticancer Res; 2010 Jan; 30(1):87-95. PubMed ID: 20150621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
    Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
    Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor.
    Zhang N; Wu P; Shayiremu D; Wu L; Shan H; Ye L; Zhao X; Cai J; Jiang WG; Gong K; Yang Y
    Int J Oncol; 2013 May; 42(5):1664-73. PubMed ID: 23545578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro.
    Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
    Int J Oncol; 2009 Dec; 35(6):1473-80. PubMed ID: 19885571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.
    Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
    Int J Mol Med; 2012 Mar; 29(3):428-34. PubMed ID: 22159313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.
    Parr C; Gan CH; Watkins G; Jiang WG
    Angiogenesis; 2006; 9(2):73-81. PubMed ID: 16758268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
    Du P; Ye L; Ruge F; Yang Y; Jiang WG
    Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
    Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
    Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
    Shen YJ; Ye DW; Yao XD; Trink B; Zhou XY; Zhang SL; Dai B; Zhang HL; Zhu Y; Guo Z; Wu G; Nagpal J
    BJU Int; 2008 Jan; 101(1):113-9. PubMed ID: 17941920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
    Xiao T; Fan JK; Huang HL; Gu JF; Li LY; Liu XY
    Cell Res; 2010 Mar; 20(3):367-78. PubMed ID: 19918267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis.
    Metheny-Barlow LJ; Li LY
    Semin Ophthalmol; 2006; 21(1):49-58. PubMed ID: 16517446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer.
    Xia G; Kumar SR; Hawes D; Cai J; Hassanieh L; Groshen S; Zhu S; Masood R; Quinn DI; Broek D; Stein JP; Gill PS
    J Urol; 2006 Apr; 175(4):1245-52. PubMed ID: 16515971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bone morphogenetic protein 7 in lung cancer and its biological impact on lung cancer cells.
    Chen J; Ye L; Xie F; Yang Y; Zhang L; Jiang WG
    Anticancer Res; 2010 Apr; 30(4):1113-20. PubMed ID: 20530416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth.
    Hou W; Medynski D; Wu S; Lin X; Li LY
    Clin Cancer Res; 2005 Aug; 11(15):5595-602. PubMed ID: 16061878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas.
    Gakiopoulou H; Nakopoulou L; Siatelis A; Mavrommatis I; Panayotopoulou EG; Tsirmpa I; Stravodimos C; Giannopoulos A
    Clin Cancer Res; 2003 Nov; 9(15):5573-81. PubMed ID: 14654538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
    Blehm KN; Spiess PE; Bondaruk JE; Dujka ME; Villares GJ; Zhao YJ; Bogler O; Aldape KD; Grossman HB; Adam L; McConkey DJ; Czerniak BA; Dinney CP; Bar-Eli M
    Clin Cancer Res; 2006 Aug; 12(15):4671-7. PubMed ID: 16899617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.